Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.9.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.9.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.9.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.64ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.64ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.64ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.64NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.221.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.221.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DP.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DP.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BL.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BL.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BL.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177.62ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177.62ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.62ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.62NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.82ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.82ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.82ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.82NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.38.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.38.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.38.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.79.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.79.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used